DPP4 and type 2 diabetes mellitus: In summary, treatment of T2DM with DPP4 inhibitors is associated with worse outcomes in twenty-seven patients who were treated with DPP4 inhibitors than in forty-nine patients who were on other glucose-lowering drugs [162].